CLINICAL_TRIALS
trial_result
· 2021-02-10
Clinical Trial Update: PAXG Out in the Country [Phase 4]
Summary
Phase 4 clinical trial update for PAXG in pancreatic ductal adenocarcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 4 | Status: UNKNOWN